{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:27:12Z","timestamp":1790227632729,"version":"4.1.0"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Continuum"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1212\/con.0000000000000698","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T18:52:30Z","timestamp":1549047150000},"page":"76-100","source":"Crossref","is-referenced-by-count":39,"title":["Behavioral Variant Frontotemporal Dementia"],"prefix":"10.1212","volume":"25","author":[{"given":"William W.","family":"Seeley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"6","key":"e_1_3_2_2_2","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/archneur.62.6.925","article-title":"Frontotemporal lobar degeneration: demographic characteristics of 353 patients","volume":"62","author":"Johnson JK","year":"2005","unstructured":"Johnson JK Diehl J Mendez MF. Frontotemporal lobar degeneration: demographic characteristics of 353 patients. Arch Neurol 2005;62(6):925\u2013930. doi:10.1001\/archneur.62.6.925.","journal-title":"Arch Neurol"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000002638"},{"issue":"2","key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4088\/JCP.10m06382oli","article-title":"The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease","volume":"72","author":"Woolley JD","year":"2011","unstructured":"Woolley JD Khan BK Murthy NK. The diagnostic challenge of psychiatric symptoms in neurodegenerative disease: rates of and risk factors for prior psychiatric diagnosis in patients with early neurodegenerative disease. J Clin Psychiatry 2011;72(2):126\u2013133. doi:10.4088\/JCP.10m06382oli.","journal-title":"J Clin Psychiatry"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awr179"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.1177\/1073858411410354"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrneurol.2018.23"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11065-012-9201-6"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-clinpsy-032813-153653"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1001\/archneurol.2007.38"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurobiolaging.2006.10.023"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awx254"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.5587-06.2007"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181bf997a"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181b9c8b9"},{"issue":"2","key":"e_1_3_2_16_2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-2011-101704","article-title":"Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred","volume":"24","author":"Pietroboni AM","year":"2011","unstructured":"Pietroboni AM Fumagalli GG Ghezzi L. Phenotypic heterogeneity of the GRN Asp22fs mutation in a large Italian kindred. J Alzheimers Dis 2011;24(2):253\u2013259. doi:10.3233\/JAD-2011-101704.","journal-title":"J Alzheimers Dis"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awm320"},{"issue":"6","key":"e_1_3_2_18_2","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/2013.jamaneurol.393","article-title":"Progranulin mutations as risk factors for Alzheimer disease","volume":"70","author":"Perry DC","year":"2013","unstructured":"Perry DC Lehmann M Yokoyama JS. Progranulin mutations as risk factors for Alzheimer disease. JAMA Neurol 2013;70(6):774\u2013778. doi:10.1001\/2013.jamaneurol.393.","journal-title":"JAMA Neurol"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2011.09.011"},{"issue":"3","key":"e_1_3_2_20_2","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1093\/brain\/aws004","article-title":"Characterization of frontotemporal dementia and\/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72","volume":"135","author":"Boeve BF","year":"2012","unstructured":"Boeve BF Boylan KB Graff-Radford NR. Characterization of frontotemporal dementia and\/or amyotrophic lateral sclerosis associated with the GGGGCC repeat expansion in C9ORF72. Brain 2012;135(pt 3):765\u2013783. doi:10.1093\/brain\/aws004.","journal-title":"Brain"},{"issue":"10","key":"e_1_3_2_21_2","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1212\/WNL.0b013e318268452e","article-title":"Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features","volume":"79","author":"Sha SJ","year":"2012","unstructured":"Sha SJ Takada LT Rankin KP. Frontotemporal dementia due to C9ORF72 mutations: clinical and imaging features. Neurology 2012;79(10):1002\u20131011. doi:10.1212\/WNL.0b013e318268452e.","journal-title":"Neurology"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awu248"},{"issue":"3","key":"e_1_3_2_23_2","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1093\/brain\/awr361","article-title":"Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features","volume":"135","author":"Mahoney CJ","year":"2012","unstructured":"Mahoney CJ Beck J Rohrer JD. Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features. Brain 2012;135(pt 3):736\u2013750. doi:10.1093\/brain\/awr361.","journal-title":"Brain"},{"issue":"5","key":"e_1_3_2_24_2","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/brain\/awr355","article-title":"Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations","volume":"135","author":"Snowden JS","year":"2012","unstructured":"Snowden JS Rollinson S Thompson JC. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain 2012;135(pt 5):693\u2013708. doi:10.1093\/brain\/awr355.","journal-title":"Brain"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.nicl.2016.12.006"},{"key":"e_1_3_2_26_2","doi-asserted-by":"publisher","DOI":"10.1176\/appi.ajp.2015.14101248"},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.3233\/JAD-170608"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70324-2"},{"issue":"11","key":"e_1_3_2_29_2","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/archneur.63.11.1627","article-title":"Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging","volume":"63","author":"Davies RR","year":"2006","unstructured":"Davies RR Kipps CM Mitchell J. Progression in frontotemporal dementia: identifying a benign behavioral variant by magnetic resonance imaging. Arch Neurol 2006;63(11):1627\u20131631. doi:10.1001\/archneur.63.11.1627.","journal-title":"Arch Neurol"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.51.6.1546"},{"key":"e_1_3_2_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/jnnp-2011-301883"},{"key":"e_1_3_2_32_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3182166e42"},{"key":"e_1_3_2_33_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2015.4668"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.5858\/arpa.2016-0469-SA"},{"issue":"1","key":"e_1_3_2_35_2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1212\/CON.0000000000000697","article-title":"Hippocampal sclerosis, argyrophilic grain disease, and primary age-related tauopathy","volume":"25","author":"Jicha GA","year":"2019","unstructured":"Jicha GA Nelson PT. Hippocampal sclerosis, argyrophilic grain disease, and primary age-related tauopathy. Continuum (Minneap Minn) 2019;25(1 Dementia):208\u2013233.","journal-title":"Continuum (Minneap Minn)"},{"key":"e_1_3_2_36_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000005163"},{"key":"e_1_3_2_37_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000173837.82820.9f"},{"key":"e_1_3_2_38_2","doi-asserted-by":"publisher","DOI":"10.1097\/JGP.0b013e318233154d"},{"issue":"2","key":"e_1_3_2_39_2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11910-015-0618-1","article-title":"Non-pharmacological management of behavioral symptoms in frontotemporal and other dementias","volume":"16","author":"Barton C","year":"2016","unstructured":"Barton C Ketelle R Merrilees J Miller B. Non-pharmacological management of behavioral symptoms in frontotemporal and other dementias. Curr Neurol Neurosci Rep 2016;16(2):14. doi:10.1007\/s11910-015-0618-1.","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"5","key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"212","DOI":"10.4088\/JCP.v58n0506","article-title":"Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors","volume":"58","author":"Swartz JR","year":"1997","unstructured":"Swartz JR Miller BL Lesser IM Darby AL. Frontotemporal dementia: treatment response to serotonin selective reuptake inhibitors. J Clin Psychiatry 1997;58(5):212\u2013216.","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000113034","article-title":"Galantamine in frontotemporal dementia and primary progressive aphasia","volume":"25","author":"Kertesz A","year":"2008","unstructured":"Kertesz A Morlog D Light M. Galantamine in frontotemporal dementia and primary progressive aphasia. Dement Geriatr Cogn Disord 2008;25(2):178\u2013185. doi:10.1159\/000113034.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"11","key":"e_1_3_2_42_2","first-page":"S46","article-title":"Behavior and treatment in frontotemporal dementia","volume":"56","author":"Perry RJ","year":"2001","unstructured":"Perry RJ Miller BL. Behavior and treatment in frontotemporal dementia. Neurology 2001;56(11 suppl 4):S46\u2013S51. doi:10.1212\/WNL.56.suppl_4.S46.","journal-title":"Neurology"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.JGP.0000231744.69631.33"},{"key":"e_1_3_2_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70320-4"},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70252-2"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.25060"},{"issue":"11","key":"e_1_3_2_47_2","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.jalz.2016.01.003","article-title":"Characterization of tau positron emission tomography tracer [18F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias","volume":"12","author":"Sander K","year":"2016","unstructured":"Sander K Lashley T Gami P. Characterization of tau positron emission tomography tracer [18F]AV-1451 binding to postmortem tissue in Alzheimer's disease, primary tauopathies, and other dementias. Alzheimers Dement 2016;12(11):1116\u20131124. doi:10.1016\/j.jalz.2016.01.003.","journal-title":"Alzheimers Dement"},{"issue":"2","key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jalz.2012.03.002","article-title":"Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development","volume":"9","author":"Boxer AL","year":"2013","unstructured":"Boxer AL Gold M Huey E. Frontotemporal degeneration, the next therapeutic frontier: molecules and animal models for frontotemporal degeneration drug development. Alzheimers Dement 2013;9(2):176\u2013188. doi:10.1016\/j.jalz.2012.03.002.","journal-title":"Alzheimers Dement"},{"issue":"47","key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"E4530","DOI":"10.1073\/pnas.1318835110","article-title":"Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration","volume":"110","author":"Lagier-Tourenne C","year":"2013","unstructured":"Lagier-Tourenne C Baughn M Rigo F. Targeted degradation of sense and antisense C9orf72 RNA foci as therapy for ALS and frontotemporal degeneration. Proc Natl Acad Sci U S A 2013;110(47):E4530\u2013E4539. doi:10.1073\/pnas.1318835110.","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Continuum"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00132979-201902000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T14:11:58Z","timestamp":1752156718000},"score":1,"resource":{"primary":{"URL":"https:\/\/continuum.aan.com\/doi\/10.1212\/CON.0000000000000698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["10.1212\/CON.0000000000000698"],"URL":"https:\/\/doi.org\/10.1212\/con.0000000000000698","relation":{},"ISSN":["1080-2371","1538-6899"],"issn-type":[{"value":"1080-2371","type":"print"},{"value":"1538-6899","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2]]}}}